We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRSN icon
451
VeriSign
VRSN
$26.3B
$3.38M 0.02%
16,433
-1,349
-8% -$259K
HBAN icon
452
Huntington Bancshares
HBAN
$34B
$3.37M 0.02%
239,099
+4,963
+2% +$71.8K
EFX icon
453
Equifax
EFX
$22B
$3.37M 0.02%
17,317
-1,258
-7% -$230K
OKE icon
454
Oneok
OKE
$56.7B
$3.35M 0.02%
51,034
-1,537
-3% -$94.5K
MOH icon
455
Molina Healthcare
MOH
$10.4B
$3.32M 0.02%
10,064
+1,557
+18% +$529K
ARE icon
456
Alexandria Real Estate Equities
ARE
$9.37B
$3.32M 0.02%
22,767
-1,681
-7% -$243K
ALT icon
457
Altimmune
ALT
$568M
$3.29M 0.02%
200,000
– –
PINS icon
458
Pinterest
PINS
$13.7B
$3.28M 0.02%
135,126
-23,096
-15% -$551K
CTLT
459
DELISTED
CATALENT, INC.
CTLT
$3.27M 0.02%
72,584
+38,355
+112% +$2.09M
CVX icon
460
Chevron
CVX
$382B
$3.25M 0.02%
18,132
-9,296
-34% -$1.62M
ITT icon
461
ITT
ITT
$17.1B
$3.24M 0.02%
+40,000
New +$3.1M
USB icon
462
US Bancorp
USB
$97.9B
$3.24M 0.02%
74,262
-214
-0.3% -$9.16K
D icon
463
Dominion Energy
D
$62.1B
$3.23M 0.02%
52,664
+46,418
+743% +$2.92M
BXMT icon
464
Blackstone Mortgage Trust
BXMT
$2.77B
$3.23M 0.02%
+152,500
New +$3.61M
OM icon
465
Outset Medical
OM
$86.4M
$3.23M 0.02%
8,328
-2,064
-20% -$582K
NDAQ icon
466
Nasdaq
NDAQ
$53.4B
$3.22M 0.02%
52,436
+20,628
+65% +$1.28M
GPN icon
467
Global Payments
GPN
$24.1B
$3.2M 0.02%
32,208
-4,474
-12% -$466K
FITB
468
Fifth Third Bancorp
FITB
$51.3B
$3.19M 0.02%
97,099
-24,877
-20% -$849K
NTLA icon
469
Intellia Therapeutics
NTLA
$1.51B
$3.18M 0.02%
91,275
-50,000
-35% -$2.38M
OXY icon
470
Occidental Petroleum
OXY
$55.7B
$3.18M 0.02%
50,523
-1,311
-3% -$89.3K
EWC icon
471
iShares MSCI Canada ETF
EWC
$6.12B
$3.18M 0.02%
97,167
– –
ORGN
472
DELISTED
Origin Materials
ORGN
$3.18M 0.02%
22,965
– –
CM icon
473
Canadian Imperial Bank of Commerce
CM
$106B
$3.16M 0.02%
78,236
-35,113
-31% -$1.55M
CAH icon
474
Cardinal Health
CAH
$53.7B
$3.12M 0.02%
40,607
-509
-1% -$38.7K
BEAM icon
475
Beam Therapeutics
BEAM
$2.68B
$3.12M 0.02%
79,665
– –
17 18
19
20 21

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.